Evaluation of feasibilty, safety and pleiotropic effects of dapagliflozin -Multicenter trial

Evaluation of feasibilty, safety and pleiotropic effects of dapagliflozin -Multicenter trial - Multicenter trial for evaluation of efficacy of dapagliflozin

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025585

Enrollment

200

Registered

2017-02-01

Start date

2017-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 2 diabetes mellitus treated with dapagliflozin

Exclusion criteria

Exclusion criteria: not applicable

Design outcomes

Primary

Measure	Time frame
HbA1c, body weight, adverse event	—

Countries

Japan

Contacts

Public ContactKunihisa Kobayashi

Fukuoka University Chikushi Hospital Department of Endocrinology and Diabetes Mellitus

nihisak@fukuoka-u.ac.jp+81-92-921-1011

Outcome results